TLR3 and esophageal squamous cell carcinoma: Therefore, it is reasonable to speculate that the high expression of TLR3 in KIRC tissues may be an active immune response, which is consistent with the conclusion of a recent study on esophageal squamous cell carcinoma (Su et al., 2022).